{"id":733,"date":"2022-09-22T20:31:53","date_gmt":"2022-09-22T20:31:53","guid":{"rendered":"https:\/\/newsletters.aans.org\/tumor\/?page_id=733"},"modified":"2022-09-27T15:19:31","modified_gmt":"2022-09-27T15:19:31","slug":"guidelines","status":"publish","type":"page","link":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/","title":{"rendered":"Guidelines"},"content":{"rendered":"<p><strong>Chair: <\/strong>Jeff Olson, MD, FAANS<img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-735 alignright\" src=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Ryan-Ormond.jpg\" alt=\"\" width=\"94\" height=\"121\" \/><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-734\" src=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Jeff-Olson.jpg\" alt=\"\" width=\"138\" height=\"121\" \/><br \/>\n<strong>Co-Chair:<\/strong> Ryan Ormond, MD<strong>, <\/strong>PhD, FAANS<br \/>\n<strong>Members: <\/strong>Garni Barkhoudarian<strong>, <\/strong>MD, FAANS, Emanuela Binello, MD, PhD, ScD, FAANS, Shawn Hervey-Jumper, MD, FAANs, Rohan Ramakrishna, MD, FAANS, Matthew Shepard, MD and Gabe Zada, MD, FAANS<\/p>\n<p>The Tumor Section Guidelines Committee continues activity on a number of fronts within neurosurgery and in neuro-oncology outside of neurosurgery. To the second point, the Joint Tumor Section was recently asked to comment on the American College of Radiology&#8217;s Appropriateness Criteria for \u201cMalignant or Aggressive Primary Musculoskeletal Tumor \u2013 Staging and Surveillance (Revised)\u201d. Prior to that, the Joint Tumor Section was asked to review the American Society for Radiation Oncology (ASTRO)-sponsored Patient-Centered Outcomes Research Institute (PCORI) commissioned Agency for Healthcare Research and Quality (AHRQ) Systematic Review for Radiation Therapy for Brain Metastases. The final draft has been reviewed by Joint Tumor Section Members and Affirmation of Educational Value was recommended.<\/p>\n<p>On the neurosurgical front, with thanks to all the Joint Tumor Section writers and writers from other specialties, the Progressive Glioblastoma Guidelines Update was published in hard copy as a special issue in the <em>Journal of Neuro-oncology<\/em> in June 2022. A new guideline in development, on a topic not previously addressed as a guideline by this organization, is the Functioning Pituitary Adenoma Guideline led by Isabelle Germano, MD, FAANS, FACS, and D. Ryan Ormond, MD, PhD, FAANS. The section is also working with the Joint Spine Section to develop a guideline document for metastatic spine tumors. Finally, the committee is fortunate to have expert volunteers from within neurosurgery and from outside specialties currently working on updates for the management of low-grade gliomas, nonfunctioning pituitary adenomas and vestibular schwannomas.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chair: Jeff Olson, MD, FAANS Co-Chair: Ryan Ormond, MD, PhD, FAANS Members: Garni Barkhoudarian, MD, FAANS, Emanuela Binello, MD, PhD, ScD, FAANS, Shawn Hervey-Jumper, MD, FAANs, Rohan Ramakrishna, MD, FAANS, Matthew Shepard, MD and Gabe Zada, MD, FAANS The Tumor Section Guidelines Committee continues activity on a number of fronts within neurosurgery and in neuro-oncology [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":673,"menu_order":12,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-733","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Guidelines - Tumor News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guidelines - Tumor News\" \/>\n<meta property=\"og:description\" content=\"Chair: Jeff Olson, MD, FAANS Co-Chair: Ryan Ormond, MD, PhD, FAANS Members: Garni Barkhoudarian, MD, FAANS, Emanuela Binello, MD, PhD, ScD, FAANS, Shawn Hervey-Jumper, MD, FAANs, Rohan Ramakrishna, MD, FAANS, Matthew Shepard, MD and Gabe Zada, MD, FAANS The Tumor Section Guidelines Committee continues activity on a number of fronts within neurosurgery and in neuro-oncology [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/\" \/>\n<meta property=\"og:site_name\" content=\"Tumor News\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-27T15:19:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Ryan-Ormond.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/\",\"name\":\"Guidelines - Tumor News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/09\\\/Ryan-Ormond.jpg\",\"datePublished\":\"2022-09-22T20:31:53+00:00\",\"dateModified\":\"2022-09-27T15:19:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/09\\\/Ryan-Ormond.jpg\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/09\\\/Ryan-Ormond.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/guidelines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tumor News Fall 2022\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/fall-2022\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Guidelines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"name\":\"Tumor News\",\"description\":\"Just another AANS Newsletter Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\",\"name\":\"Tumor News\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"width\":2336,\"height\":2294,\"caption\":\"Tumor News\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guidelines - Tumor News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/","og_locale":"en_US","og_type":"article","og_title":"Guidelines - Tumor News","og_description":"Chair: Jeff Olson, MD, FAANS Co-Chair: Ryan Ormond, MD, PhD, FAANS Members: Garni Barkhoudarian, MD, FAANS, Emanuela Binello, MD, PhD, ScD, FAANS, Shawn Hervey-Jumper, MD, FAANs, Rohan Ramakrishna, MD, FAANS, Matthew Shepard, MD and Gabe Zada, MD, FAANS The Tumor Section Guidelines Committee continues activity on a number of fronts within neurosurgery and in neuro-oncology [&hellip;]","og_url":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/","og_site_name":"Tumor News","article_modified_time":"2022-09-27T15:19:31+00:00","og_image":[{"url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Ryan-Ormond.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/","url":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/","name":"Guidelines - Tumor News","isPartOf":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#website"},"primaryImageOfPage":{"@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/#primaryimage"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Ryan-Ormond.jpg","datePublished":"2022-09-22T20:31:53+00:00","dateModified":"2022-09-27T15:19:31+00:00","breadcrumb":{"@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/#primaryimage","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Ryan-Ormond.jpg","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2022\/09\/Ryan-Ormond.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/guidelines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/newsletters.aans.org\/tumor\/"},{"@type":"ListItem","position":2,"name":"Tumor News Fall 2022","item":"https:\/\/newsletters.aans.org\/tumor\/fall-2022\/"},{"@type":"ListItem","position":3,"name":"Guidelines"}]},{"@type":"WebSite","@id":"https:\/\/newsletters.aans.org\/tumor\/#website","url":"https:\/\/newsletters.aans.org\/tumor\/","name":"Tumor News","description":"Just another AANS Newsletter Sites site","publisher":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/newsletters.aans.org\/tumor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/newsletters.aans.org\/tumor\/#organization","name":"Tumor News","url":"https:\/\/newsletters.aans.org\/tumor\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","width":2336,"height":2294,"caption":"Tumor News"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/comments?post=733"}],"version-history":[{"count":7,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/733\/revisions"}],"predecessor-version":[{"id":823,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/733\/revisions\/823"}],"up":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/673"}],"wp:attachment":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/media?parent=733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}